ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Keith A. Horvath
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mouli, S. K.
Right arrow Articles by Horvath, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mouli, S. K.
Right arrow Articles by Horvath, K. A.
Related Collections
Right arrow Coronary disease

Ann Thorac Surg 2004;78:1326-1331
© 2004 The Society of Thoracic Surgeons


Original article: cardiovascular

What is the Optimal Channel Density for Transmyocardial Laser Revascularization?

Samdeep K. Mouli, BSa, Jeffrey Fronza, BSa, Rodney Greene, BSa, Emmanuel S. Robert, MSa, Keith A. Horvath, MDa,*

a Division of Cardiothoracic Surgery, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA

Accepted for publication April 14, 2004.

* Address reprint requests to Dr Horvath, Division of Cardiothoracic Surgery, Northwestern University Medical School, 201 E Huron St, Galter 10-105, Chicago, IL 60611, USA
khorvath{at}nmh.org

Presented at the Fortieth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, Jan 26–28, 2004.

BACKGROUND: Transmyocardial laser revascularization (TMR) has demonstrated reproducible relief of angina in patients with end-stage coronary disease. However, the optimum dose or channel density has not been elucidated.

METHODS: Using a porcine model of chronic myocardial ischemia, 14 animals were treated with CO2 TMR and randomized as follows: group 1 was 1 channel per 2 cm2; group 2 was 1 channel per 1 cm2; and group 3 was 2 channels per 1 cm2. Left ventricular myocardial viability and function were assessed by magnetic resonance imaging (MRI) and echocardiography pretreatment, and repeated 6 weeks later.

RESULTS: The MRI assessment of group 1 (1 channel/2 cm2) and group 2 (1 channel/cm2) demonstrated similar improvement in segmental contractility posttreatment of 12.11% ± 5.15% and 12.47% ± 9.51%, respectively. In contrast, group 3 (2 channels/cm2) showed significantly worse segmental contractility posttreatment: –18.52% ± 7.16% (p = 0.01). Echocardiographic imaging revealed significant improvements in wall thickening in the ischemic zone for group 1 at 0.91 ± 0.07 cm pretreatment versus 1.30 ± 0.09 cm posttreatment, (p = 0.01); and for group 2 at 0.93 ± 0.11 cm versus 1.42 ± 0.18 cm, (p = 0.01). No significant improvement in wall thickening was seen in group 3 (0.84 ± 0.06 cm versus 0.88 ± 0.09 cm, p = n.s.).

CONCLUSIONS: These data corroborate the empiric finding of an effective therapeutic dose range for TMR, 1 channel per 1 to 2 cm2. These results also demonstrate a detrimental effect when channel density is increased above the clinical standard of 1 channel per cm2 to a density of 2 channels per 1 cm2.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
P. Atluri, C. M. Panlilio, G. P. Liao, E. E. Suarez, R. C. McCormick, W. Hiesinger, J. E. Cohen, M. J. Smith, A. B. Patel, W. Feng, et al.
Transmyocardial revascularization to enhance myocardial vasculogenesis and hemodynamic function.
J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 283 - 291.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. B. Leon, R. Kornowski, W. E. Downey, G. Weisz, D. S. Baim, R. O. Bonow, R. C. Hendel, D. J. Cohen, E. Gervino, R. Laham, et al.
A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease
J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1812 - 1819.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.